Status | Study |
NOT_YET_RECRUITING |
Study Name: Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor Condition: Date: 2023-06-07 Interventions: Paclitaxel will be administered at 80mg/m2/day every four weeks at Day 1, Day 8 and Day 15 per cycle.One cycle consists of 4 weeks |
Active, not recruiting |
Study Name: Ripretinib in Chinese Patients With Advanced GIST: a Real World Study Condition: Gastrointestinal Stromal Tumors Date: 2023-01-15 Interventions: Drug: Ripretinib Oral TabletOral kinase inhibitor |
NOT_YET_RECRUITING |
Study Name: Imatinib TDM in GIST Condition: Gastrointestinal Stromal Tumors Date: 2022-08-05 Interventions: Therapeutic drug level monitoring with plans to increase to adjust drug dosage based on levels and patient symptoms. |
RECRUITING |
Study Name: ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST Condition: Gastrointestinal Stromal Tumors Date: 2022-05-05 Interventions: 37.5 mg of Sunitinib orally (PO), once daily on a 28-day treatment cycle. |
Recruiting |
Study Name: Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor Condition: Gastrointestinal Stromal Tumor Date: 2016-10-11 Interventions: Procedure: surgery or biopsy Do radical surgery or biopsy to obtain a pathological result |
Active, not recruiting |
Study Name: A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor Condition: Gastrointestinal Stromal Tumor Date: 2015-01-08 Interventions: Drug: Famitinib |
Active, not recruiting |
Study Name: A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib Condition: Gastrointestinal Stromal Tumors Date: 2012-08-22 Interventions: Drug: Masitinib 12 mg/kg/day |
Completed |
Study Name: A Phase 2 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib Condition: Gastro Intestinal Stromal Tumor Date: 2012-01-03 Interventions: Drug: masitinib masitinib 12 m |
Completed |
Study Name: Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors Condition: Gastrointestinal Stromal Tumors Date: 2011-01-10 Interventions: Drug: Everolimus Other Name: R |
Completed |
Study Name: Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor Condition: Gastrointestinal Stromal Tumor Date: 2010-12-27 Interventions: Drug: imatinib mesylate Patien |